190
Views
6
CrossRef citations to date
0
Altmetric
Perspectives

Medication Exchange and Sharing Network Program (MESNP) initiative to cope with drug shortages in the Kingdom of Saudi Arabia (KSA)

ORCID Icon &
Pages 115-121 | Published online: 09 Jul 2019

References

  • Gray A, Manasse H. Shortages of medicines: a complex global challenge. Bull World Health Organ 2012;90(3):158–158A. doi:10.2471/BLT.11.101303
  • Casassus B. Europe urged to take action on drug shortages. The Lancet. 2015;385(9975):1279–1280. doi:10.1016/S0140-6736(15)60667-5
  • Morrison A. Drug Supply Disruptions [Environmental Scan Issue 17]. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2011.
  • Ventola CL. The drug shortage crisis in the United States: causes, impact, and management strategies. P T. 2011;36:740–757.22346307
  • Birgli AG. An Evaluation of Medicines Shortages in Europe with a More In-Depth Review of These in France, Greece, Poland, Spain, and the United Kingdom. Zurich: Birgli AG; 2013 Available from: http://static.correofarmaceutico.com/docs/2013/10/21/evaluation.pdf. Accessed 407, 2019.
  • Costelloe EM, Guinane M, Nugent F, Halley O, Parsons C. An audit of drug shortages in a community pharmacy practice. Ir J Med Sci. 2015;184:435. doi:10.1007/s11845-014-1139-724859372
  • Butterfield L, Cash J, Pham K. Advocacy committee for the pediatric pharmacy advocacy group. Drug shortages and implications for pediatric patients. J Pediatr Pharmacol Ther. 2015;20(2):149–152. doi:10.5863/1551-6776-20.2.14925964733
  • De Weerdt E, Simoens S, Casteels M, et al. Clinical, economic and policy implications of drug shortages in the European union. Appl Health Econ Health Policy. 2017;15(4):441–445. doi:10.1007/s40258-016-0264-z27480539
  • De Weerdt E, Simoens S, Hombroeckx L, et al. Causes of drug shortages in the legal pharmaceutical framework. Regul Toxicol Pharmacol. 2015;71(2):251–258. doi:10.1016/j.yrtph.2015.01.00525591547
  • Heiskanen K, Ahonen R, Kanerva R, Karttunen P, Timonen J, Bochenek T. The reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland. PLoS One. 2017;12(6):e0179479. doi:10.1371/journal.pone.017947928658307
  • Yang C, Wu L, Cai W, et al. Current situation, determinants, and solutions to drug shortages in Shaanxi Province, China: a qualitative study. PLoS One. 2016;11(10):e0165183. doi:10.1371/journal.pone.016518327780218
  • Mazer-Amirshahi M, Goyal M, Umar SA, et al. U.S. drug shortages for medications used in adult critical care (2001–2016). J Crit Care. 2017;41:283–288. doi:10.1016/j.jcrc.2017.06.00528622641
  • Walker J, Chaar BB, Vera N, et al. Medicine shortages in Fiji: a qualitative exploration of stakeholders’ views. PLoS One. 2017;12(6):e0178429. doi:10.1371/journal.pone.017842928582409
  • Alsheikh M, Seoane-Vazquez E, Rittenhouse B, Fox ER, Fanikos J. A comparison of drug shortages in the hospital setting in the United States and Saudi Arabia: an exploratory analysis. J Hosp Pharm. 2016;51(5):370–375. doi:10.1310/hpj5105-370
  • Awad H, Awad H, Al-Zu’bi ZMF, et al. A quantitative analysis of the causes of drug shortages in Jordan: a supply chain perspective. Int Bus Res Int Bus Res. 2016;9:53. doi:10.5539/ibr.v9n6p53
  • Klobuchar SA. Shortages of cancer drugs in the USA. Lancet Oncol. 2011;12:313. doi:10.1016/S1470-2045(11)70150-421463830
  • Kaakeh R, Sweet BV, Reilly C, et al. Impact of drug shortages on U. S. health systems. Am J Health Syst Pharm. 2011;68(19):1811–1819. doi:10.2146/ajhp11021021930639
  • Fox ER, Birt A, James KB, Kokko H, Salverson S, Soflin DL. ASHP guidelines on managing drug product shortages in hospitals and health systems. Am J Health-Syst Pharm. 2009;66:1399. doi:10.2146/ajhp09002619635779
  • Jenks S. Efforts underway to curb drug shortages. J Natl Cancer Inst. 2011;103(12):914–915. doi:10.1093/jnci/djr23421693752
  • McKenna M. Hospital pharmacists scrambling amid vast drug shortages: emergency physicians between a rock and a hard place. Ann Emerg Med. 2011;57:A13–A15.21322165
  • Johnson TJ. Drug shortages: an increasing problem for patients and clinicians. S D Med. 2011;64(1):14–15.21337920
  • Dal MF. BCG shortage in Europe. Prev Med. 2013;57:146. doi:10.1016/j.ypmed.2013.04.01923648524
  • Giraldo P, Irun P, Alfonso P, et al. Evaluation of Spanish gaucher disease patients after a 6-month imiglucerase shortage. Blood Cells Mol Dis. 2011;46(1):115–118. doi:10.1016/j.bcmd.2010.09.00520934891
  • Linthorst GE, Burlina AP, Cecchi F, et al. Recommendations on reintroduction of agalsidase beta for patients with fabry disease in Europe, following a period of shortage. JIMD Rep. 2013;8:51–56. doi:10.1007/8904_2012_16023430520
  • Tirelli U, Berretta M, Spina M, et al. Oncologic drug shortages also in Italy. Eur Rev Med Pharmacol Sci. 2012;16:138–139.
  • Furness H. Drug Shortage Caused by Sale to EU. London: Telegraph; 2012:15–5.
  • European association of hospital pharmacists: medicine shortages in European hospitals. Available from: http://www.eahp.eu/practice-and-policy/medicines-shortages. Accessed 410, 2019.
  • Capstick TG, Laycock D, Lipman MC. Treatment interruptions and inconsistent supply of anti-tuberculosis drugs in the United Kingdom. Int J Tuberc Lung Dis. 2011;15:754–760. doi:10.5588/ijtld.10.0568.21575294
  • Bochenek T, Abilova V, Alkan A, et al. Systemic measures and legislative and organizational frameworks aimed at preventing or mitigating drug shortages in 28 European and Western Asian Countries. Front Pharmacol. 2018;8:942. doi:10.3389/fphar.2017.00942.29403372
  • AL-Aqeel SA, AL-Salloum HF, Abanmy NO, et al. Undispensed prescriptions due to drug unavailability at a teaching hospital in Saudi Arabia. Int J Health Res. 2010;3(4):213–216.
  • AlRuthia YS, Alwahibi M, Alotaibi MF, et al. Drug shortages in Saudi Arabia: root causes and recommendations. Saudi Pharm J. 2018;26(7):947–951. doi:10.1016/j.jsps.2018.05.00230416350
  • Drug shortages roundtable: minimizing the impact on patient care. Am J Health-Syst Pharm. 2018;75(11):816–820. doi:10.2146/ajhp18004829802115
  • O’Brien L Improving supply chain efficiencies in the safety net: an inventory management pilot program for free and charitable clinics 2013. Available from: http://www.safetynetcenter.org/sites/default/files/images/Vecna%20Cares%20Overview%203%2015. Accessed 710, 2018.
  • World Health Organization. Addressing the Global Shortages of Medicines, and the Safety and Accessibility of Children’s Medication – EB138/41. Geneva: WHO; 2015.
  • Iyengar S, Hedman L, Forte G, et al. Medicine shortages: a commentary on causes and mitigation strategies. BMC Med. 2016;14(1):124. doi:10.1186/s12916-016-0674-727683105
  • U.S. FDA. Strategic plan for preventing and mitigating drug shortages; 2013 Accessed 410, 2018.
  • U.S. FDA. Drug Shortages: non-Compliance With Notification Requirement. Available from: https://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm403902.htm Accessed 408, 2019.
  • Flowchart. Available from: http://www.ihi.org/resources/Pages/Tools/Flowchart.aspx. Accessed 707, 2018.
  • Antonacci G, Reed JE, Lennox L, Barlow J. The use of process mapping in healthcare quality improvement projects. Health Serv Manage Res. 2018 31(2):74–84. doi:10.1177/095148481877041129707978
  • Abukhousa E, Al-Jaroodi J, Lazarova-Molnar S, Mohamed N. Simulation and modeling efforts to support decision making in healthcare supply chain management. Sci World J. 2014. doi:10.1155/2014/354246.354246
  • AlAzmi A, AlHamdan H, Abualezz R, et al. Patients’ knowledge and attitude toward the disposal of medications. J Pharm(Cairo). 2017;2017:8516741. doi:10.1155/2017/851674129130019
  • Vail E, Gershengorn HB, Hua M, et al. Association between US norepinephrine shortage and mortality among patients with septic shock. JAMA. 2017;317(14):1433–1442. doi:10.1001/jama.2017.284128322415
  • Almalki M, Fitzgerald G, Clark M. Health care system in Saudi Arabia: an overview. EMHJ. 2011;17(10).
  • Saudi Vision 2030. Available from: https://vision2030.gov.sa/download/file/fid/417. Accessed 807, 2018.
  • Drug Shortages Continue to Compromise Patient Care. ISMP Medication Safety Alert! Acute Care Edition. 1 11, 2018; Vol. 23: 1–4.
  • Canadian Generic Pharmaceutical Association. Canadian Generic Pharmaceutical Association (CGPA) best practices guidelines for the prevention, notification and management of drug shortages. Available from: http://canadiangenerics.ca/wp-content/uploads/19192016/09/BestPracticesGuidelines2013.pdf. Accessed 410, 2019.
  • Available from: https://www.fda.gov/downloads/aboutfda/workingatfda/fellowshipinternshipgraduatefacultyprograms/pharmacystudentexperientialprogramcder/ucm528194.pdf. Accessed 410, 2019.
  • UNSG high-level panel on access to medicines. Available from: www.unsgaccessmeds.org. Accessed 404, 2019.
  • Ferrario A, Araja D, Bochenek T, et al. The implementation of managed entry agreements in central and Eastern Europe: findings and implications. Pharmacoeconomics. 2017;35:1271–1285. doi:10.1007/s40273-017-0559-428836222